At Aparito we’re involved in various projects across different study types including the development of novel digital endpoints, hybrid clinical trials and fully decentralised clinical trials.

1. Operationalizing
2. Technology in Progress
3. Live Study
4. Completed Study
Technology in Progress
Live Study
Completed Study
Pivotal Regulated Study
Late Onset Pompe Disease (LOPD)
Gaucher Disease – Type 2
MPSIII (Sanfilippo Syndrome)
Ornithine transcarbamylase (OTC) deficiency
Cerebral Cavernous Malformation (CCM)
Osteogenesis Imperfecta
Batten Disease
Dystonia (Sleep Quality)
Incontinence and Soiling
Pre-hab for Gynaecology Surgery
Gaucher Disease – Type 1
Neurodegenerative Disease in Adults
Digital Endpoint Development
Neurodegenerative Disease
Proof of Concept / Feasibility Study
Juvenile Idiopathic Arthritis (JIA)
Niemann-Pick Disease Type C (NPC)
Duchenne Muscular Dystrophy
Paediatric Refractory Epilepsy
Natural History Study
Late Onset GM2 Gangliosidosis
Global Disease Registry
Neuropathic Gaucher Disease

Ready to get started?

Share your study requirements and unlock the potential of Atom5™ for your clinical trial!